Displaying drugs 1076 - 1100 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Umeclidinium | 428.595 C29H34NO2 |  | A long-acting muscarinic antagonist used as a long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). | Agents producing tachycardia |
| Edoxaban | 548.06 C24H30ClN7O4S |  | A novel oral anticoagulant used for reducing the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF). | Direct factor Xa inhibitors / Factor Xa Inhibitors |
| Olaparib | 434.4628 C24H23FN4O3 |  | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. | Poly (ADP-ribose) polymerase (PARP) inhibitors |
| Palbociclib | 447.5328 C24H29N7O2 |  | An endocrine-based chemotherapeutic agent used in combination with other antineoplastic agents to treat HER2-negative and HR-positive advanced or metastatic breast cancer. | Cyclin-dependent kinase (CDK) inhibitors / Protein Kinase Inhibitors |
| Sodium oxybate | 126.087 C4H7NaO3 |  | A central nervous system depressant used to treat cataplexy and excessive daytime sleepiness (EDS) associated with narcolepsy. | Adjuvants, Anesthesia / Anesthetics, Intravenous / Central Nervous System Depressants / Hydroxybutyrates |
| Tasimelteon | 245.322 C15H19NO2 |  | A melatonin receptor agonist used to treat Non- 24-Hour Sleep-Wake Disorder. | Melatonin Receptor Agonists / Receptors, Melatonin, agonists |
| Tibolone | 312.453 C21H28O2 |  | For the relief of post-menopausal symptoms and for the prevention of osteoporosis . | Anabolic Agents / Antineoplastic Agents, Hormonal / Estrogen Receptor Modulators |
| Trimetazidine | 266.341 C14H22N2O3 |  | A piperazine derivative indicated as an adjunct therapy in symptomatic treatment of stable angina pectoris. | Piperazines / Vasodilating Agents |
| Vortioxetine | 298.45 C18H22N2S |  | A serotonin modulating antidepressant indicated for the treatment of major depressive disorder (MDD). | Agents that produce hypertension |
| Cobicistat | 776.03 C40H53N7O5S2 |  | A CYP3A inhibitor used to increase the systemic exposure of atazanavir or darunavir in combination with other antiretroviral agents in the treatment of HIV-1 infection. | Anti-HIV Agents / Carbamates / Cytochrome P-450 CYP3A Inhibitors / Thiazoles |
| Ciprofibrate | 289.15 C13H14Cl2O3 |  | Not Annotated | Fibric Acids |
| Ceritinib | 558.135 C28H36ClN5O3S |  | An antineoplastic kinase inhibitor used to treat anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) in patients with inadequate clinical response or intolerance to crizotinib. | Anaplastic lymphoma kinase (ALK) inhibitors / Protein Kinase Inhibitors |
| Cannabidiol | 314.469 C21H30O2 |  | An active cannabinoid used as an adjunctive treatment for the management of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome and symptomatic relief of moderate to severe neuropathic pain or other painful conditions, like cancer. | Agents producing tachycardia / Agents that produce hypertension |
| Avibactam | 265.24 C7H11N3O6S |  | A non-β-lactam β-lactamase inhibitor used in combination with ceftazidime for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, and hospital or ventilator-acquired pneumonia. | beta-Lactamase Inhibitors |
| Atosiban | 994.19 C43H67N11O12S2 |  | An inhibitor of oxytocin and vasopressin used to delay imminent preterm birth in pregnant adult women displaying specific clinical observations. | Hormone Antagonists / Tocolytic Agents |
| Amorolfine | 317.517 C21H35NO |  | A morpholine derivative commonly applied as a lacquer for onychomycosis but is also used for superficial dermatomycosis. | Antifungal Agents |
| Acipimox | 154.125 C6H6N2O3 |  | A niacin derivative used in Fredrickson type IIb and type IV hyperlipoproteinemia. | Nicotinic Acid and Derivatives |
| Idelalisib | 415.432 C22H18FN7O |  | An antineoplastic kinase inhibitor used to treat chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed small lymphocytic lymphoma (SLL). | Phosphatidylinositol-3-kinase (Pi3K) inhibitors |
| Ibrutinib | 440.507 C25H24N6O2 |  | An antineoplastic agent used to treat chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's Macroglobulinemia. | Bruton's tyrosine kinase (BTK) inhibitors / Protein Kinase Inhibitors |
| Ceftolozane | 666.69 C23H30N12O8S2 |  | A cephalosporin antibiotic used to treat complicated intra-abdominal infections in combination with metronidazole, complicated urinary tract infections, and hospital-acquired pneumonia. | Anti-Bacterial Agents / Cephalosporins |
| Naloxegol | 651.794 C34H53NO11 |  | A peripherally-selective opioid antagonist used to treat opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain. | Peripheral Opioid Receptor Antagonists |
| Netupitant | 578.603 C30H32F6N4O |  | An antiemetic agent used in combination with palonosetron to prevent acute and delayed vomiting and nausea caused by chemotherapy. | Substance P/Neurokinin-1 Receptor Antagonist |
| Finafloxacin | 398.394 C20H19FN4O4 |  | Finafloxacin is indicated for the treatment of acute otitis externa (AOE) with or without an otowick, caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus in patients age 1... | Anti-Bacterial Agents / Anti-Infective Agents, Urinary / Quinolone Antimicrobial / Topoisomerase II Inhibitors |
| Tedizolid phosphate | 450.323 C17H16FN6O6P |  | An oxazolidinone class antibiotic that inhibits bacterial protein synthesis and is proven to be effective in the treatment of certain Gram-positive bacterial infections. | Anti-Bacterial Agents / Oxazolidinone Antibacterial |
| Tavaborole | 151.93 C7H6BFO2 |  | An antifungal agent used to treat onychomycosis, a fungal infection of the nail. | Antifungal Agents / Oxaborole Antifungal |
Displaying drugs 1076 - 1100 of 2785 in total